Host: Mouse

Isotype: IgG1

Immunogen: human urine urokinase plasminogen activator

Form: Lyophilized

Formulation: Lyophilized from a volatile buffer, 100 µg of BSA.

Preservative: None

Positive Control: Concentrated conditioned medium from HT-1080 cells or carcinoma tissue

Comments: Recognizes uPA/PAI complexes and receptor-bound uPA in HT-1080 cells or carcinoma tissue. Sold under license of U.S. Patent 5,422,245.

Ref.: Foekens, J. A., et al. 1992. Cancer Res. 52, 6101. Andreasen, P. A., et al. 1990. Mol. Cell. Endocrinol. 68, 1. Blasi, F. and Verde, P., 1990. in Seminars in Cancer Biology, ed. M. M. Gottesman. Vol. 1, 153. Duffy, M. J., et al. 1990. Cancer Res. 50, 6827. Jänicke, F., et al. 1990. Fibrinolysis 4, 69. Blasi, F., et al. 1987. J. Cell Biol. 104, 801. Nielsen, L. S., et al. 1986. J. Immunoassay. 7, 209.

Sold under license of U.S. Patent 5,422,245.